2018 CLINICAL CONFERENCE at the National Ryan White Conference on HIV Care & Treatment
Sunday, December 9, 2018 to Tuesday, December 11, 2018
Who Should Attend
Attendance is limited to 600 HIV physicians, nurse practitioners, and physician assistants in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs. A limited number of spots are reserved for RNs and PharmDs who are the primary clinical decision makers in their RWHAP-funded clinics or programs.
Attendance to this 2018 CLINICAL CONFERENCE is limited, and all attendees must be approved. Please do not book hotel accommodations or make travel arrangements prior to receiving notification that your application to attend has been approved.
** If you do not receive an application status notification within 2 business days of submitting your application, please check your spam folder. Otherwise, please email firstname.lastname@example.org.
2018 CLINICAL CONFERENCE Description
The 2018 CLINICAL CONFERENCE will provide state-of-the-art updates on research, care, and treatment issues in the medical management of HIV infection for experienced HIV clinical decision makers.
The 2018 CLINICAL CONFERENCE is coordinated through the RWHAP AIDS Education and Training Centers (AETC) clinician training network. A mix of lectures, case-based interactive presentations, and small-group workshop breakout sessions will be held during the three days of the 2018 CLINICAL CONFERENCE. It will conclude immediately before the opening general session of the National Conference.
The educational objectives for the 2018 CLINICAL CONFERENCE are designed and developed based on the identified needs and knowledge gaps of the attendees.
On completion of the 2018 CLINICAL CONFERENCE, participants will be able to:
- Describe the new aspects to the Ryan White HIV/AIDS Program
- Describe new insights into HIV disease pathogenesis that impact clinical care, including opportunities for researching HIV cure
- Describe the most recent advances in antiretroviral therapy, including initial regimens, switching therapy, and investigational new drugs and approaches
- Describe the practical aspects of care for older HIV-infected patients
- Identify chronic opioid dependent patients and develop treatment strategies for the management of these patients with opioid substitution therapy
- Apply new research data to the prevention of HIV infection, pre- and postexposure
- Describe the intersection between intimate partner violence and the increased risk of HIV infection
- Formulate state-of-the-art strategies for diagnosing and managing opportunistic infections, cardiovascular disease, and sexually transmitted infections in patients with HIV infection
- Identify the elements of the care continuum, including testing, engagement, treatment, and retention in care and their challenges
- Develop strategies for eradicating hepatitis C virus from your clinic
- Formulate treatment strategies for the management of liver-related complications
Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 19.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 19.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Academy of Family Physicians Credits
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 19.50 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 19.5 hour (1.95 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
This conference is funded by Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686 (AIDS Education and Training Center National Coordinating Resource Center) awarded François-Xavier Bagnoud Center from the Rutgers University School of Nursing with a sub award to International Antiviral Society–USA (IAS–USA) to sponsor this CME activity. There is no registration fee to attend. Attendees are responsible for their transportation expenses to and from Washington, DC, hotel stay costs, meals, and all other expenses. Please check with your project officer about expenses that are covered by your RWHAP award.